Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

Market Cap	99.55B +1.4%
Revenue (ttm)	77.80B -18.6%
Net Income	12.94B -41.4%
EPS	2,120.00 -41.4%
Shares Out	6.10M
PE Ratio	7.69
Forward PE	n/a
Dividend	850.00 (5.18%)
Ex-Dividend Date	Dec 29, 2025

Volume	6,604
Average Volume	4,621
Open	16,400
Previous Close	16,410
Day's Range	16,160 - 16,480
52-Week Range	14,730 - 19,250
Beta	0.24
RSI	61.05
Earnings Date	May 12, 2026

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con...

• Industry: Pharmaceutical Preparations
• Founded: 1945
• Employees: 300
• Stock Exchange: KOSDAQ
• Ticker Symbol: 009300

Financial Performance

In 2025, Sam-A Pharm.'s revenue was 77.80 billion, a decrease of -18.60% compared to the previous year's 95.58 billion. Earnings were 12.94 billion, a decrease of -41.39%.